| Literature DB >> 24642596 |
Raghavendra Pralhada Rao1, Luana Scheffer1, Sargur M Srideshikan1, Velayoudame Parthibane1, Teresa Kosakowska-Cholody1, M Athar Masood2, Kunio Nagashima3, Prabhakar Gudla4, Stephen Lockett4, Usha Acharya5, Jairaj K Acharya1.
Abstract
Ceramide transfer protein (CERT) transfers ceramide from the endoplasmic reticulum (ER) to the Golgi complex. Its deficiency in mouse leads to embryonic death at E11.5. CERT deficient embryos die from cardiac failure due to defective organogenesis, but not due to ceramide induced apoptotic or necrotic cell death. In the current study we examined the effect of CERT deficiency in a primary cell line, namely, mouse embryonic fibroblasts (MEFs). We show that in MEFs, unlike in mutant embryos, lack of CERT does not lead to increased ceramide but causes an accumulation of hexosylceramides. Nevertheless, the defects due to defective sphingolipid metabolism that ensue, when ceramide fails to be trafficked from ER to the Golgi complex, compromise the viability of the cell. Therefore, MEFs display an incipient ER stress. While we observe that ceramide trafficking from ER to the Golgi complex is compromised, the forward transport of VSVG-GFP protein is unhindered from ER to Golgi complex to the plasma membrane. However, retrograde trafficking of the plasma membrane-associated cholera toxin B to the Golgi complex is reduced. The dysregulated sphingolipid metabolism also leads to increased mitochondrial hexosylceramide. The mitochondrial functions are also compromised in mutant MEFs since they have reduced ATP levels, have increased reactive oxygen species, and show increased glutathione reductase activity. Live-cell imaging shows that the mutant mitochondria exhibit reduced fission and fusion events. The mitochondrial dysfunction leads to an increased mitophagy in the CERT mutant MEFs. The compromised organelle function compromise cell viability and results in premature senescence of these MEFs.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24642596 PMCID: PMC3958450 DOI: 10.1371/journal.pone.0092142
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Cert MEFs undergo senescence and have dysregulated sphingolipid metabolism.
(A) Cell viability assay of Cert and Cert MEFs by MTT assay. (B) Mitotic index of Cert MEFs measured over seven passages (C) The MEFs were analyzed by FACS analysis (representative plots on the left) using propidium iodide for staining cells and the percentage of cells in G1 phase measured and plotted (right panel). The actual raw data from a representative experiment along with the multiline plot generated using ModFit LT computer software is shown in the left panels. The red histograms show the percent cells in G1 and G2/M phase while the hatched plot shows the cells in S phase. (D) Upregulation of p16 Cert MEFs. (E) Morphological analysis of late passage cells from control and mutant MEFs. The mutant MEFs show flattened morphology typical of senescent cells. (F) The total sphingomyelin and (G) total ceramide was decreased while total hexosylceramides (H) were increased in the in Cert compared to MEFs derived from Cert as measured by mass spectrometry. (I) Metabolic labeling with radiolabeled serine showed that the levels of sphingomyelin synthesized by the de novo pathway is decreased, while hexosylceramide is increased during the period of pulse chase. (J) The quantification of hexosylceramides from three metabolic labeling experiments is shown. The bands representing hexosylceramides were scraped and counted in a liquid scintillation counter and normalized to the wild type levels.
Figure 2CERT deficiency leads to incipient ER stress in Cert MEFs.
(A) The total ER ceramide levels are slightly decreased while (B) hexosylceramide levels are increased in Cert compared to the control Cert MEFs. (C) Basal PDI levels are increased in the mutant MEFs. Upon serum starvation the levels of IRE1α and BiP are increased in the mutant cells. (D) The ER was labeled with ER tracker green. The ER in the mutant show altered morphology and altered dynamics (see videos S1 and S2). (E). Metabolic labeling for phospholipids were performed using 32P-orthophosphoric agent as a substrate. No visible difference in major phospholipids was observed between the wild type control and the mutant cells. (F) qPCR analysis of transcripts for GLUCS and GALCS shows increased transcript levels in P5 Cert compared to the CertMEFs.
Figure 3Altered Golgi dynamics in Cert MEFs.
(A) The Golgi architecture seems to be normal as evidenced by immunofluorescence staining using a Golgi marker (GM130) and (B) The ultrastructure of Golgi seems apparently normal although we see a slightly more fragmented pattern of Golgi compared to the wild type. N- denotes the nucleus and the arrows indicated the Golgi cisternae. (C) The MEFs were incubated with DMB-C5-Cer as described under materials and methods. While perinuclear concentration of the ceramide is clearly visible in Cert the Cert show a diffuse staining indicating a lack of transport of ceramide from the ER to the Golgi complex. (D) Recycling of cargo protein cholera toxin B (CTxB, associated with lipid rafts) between the plasma membrane and the Golgi complex is impaired in the mutant MEFs. (E) Quantification of the extent of recovery after photobleaching.
Figure 4Mitochondrial dysfunction and mitophagy in Cert MEFs.
(A) Live cell imaging of mitochondria show that mutant mitochondria appear fragmented and have decreased fusion and fission events (see videos S3 and S4). (B) A measure of pixel variation was used to quantitate the mitochondrial dynamics as described in materials and methods under mitochondria segmentation and tracking. While pixel length change dramatically in the wild type over the period of observation (16 min) the movement of the mutant mitochondria was dramatically reduced viz. the length of the mitochondria measured in pixels is changed in wild-type much more than in the mutants (C) The amount of ROS generated was detected using MitoSox reagent and imaged under 514 nm excitation. Increased ROS generation can be observed in Cert MEFs. (D) Glutathione reductase activity is increased while (E) ATP levels are decreased in the mutant cells. (F) Mitochondrial ceramide levels are decreased while (G) the monohexosylceramides are increased in the Cert cells. (H-I) Electron micrographs of passage 6 Cert MEF (upper left panel) and a passage 5 Cert MEF (upper right panel) shows increased autophagic vacuoles in the latter seen as dark multivesicular structures. A passage 3 Cert MEF showing active mitophagy (lower left panel). The boxed area has been enlarged in the lower right panel showing several mitochondria in various stages of mitophagy. Black arrows show double membrane structure enveloping intact mitochondrion and some in early to mid-stage autophagic degradation. White arrow heads late stage autophagosome. (I) The number of autophagic vacuoles counted from EM images of passage 3 MEFs was counted (n = 15) and the average number was plotted as autophagic index. (J) LC3B staining of Cert and Cert MEFs. (K) More than 200 cells were counted for each genotype and cells showing more than 5 punctae that were larger and brighter than background staining were considered positive and plotted. (L) Western analysis of LC3 in the control and mutant MEFs.